Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?86.83

?86.83

 
WKN: A2DKZC / Symbol: VRNA / Name: Verona Pharma / Stock / Small Cap /
Latest predictions
€86.01
08.10.25
-
buy
€144.28
01.07.25
-
buy
€139.15
23.06.25
-
buy
€119.87
20.06.25
-
buy
€100.90
18.06.25
-
buy
€96.42
11.06.25
-
buy
Your prediction

Verona Pharma plc Stock

Verona Pharma plc is currently one of the favorites of our community with 20 Buy predictions and no Sell predictions.
Based on the current price of 0.51 € the target price of 86 € shows a potential of 16929.7% for Verona Pharma plc which would more than double the current price.

Pros and Cons of Verona Pharma plc in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -
Target price 86.010
Change
Ends at 08.10.26

Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $100.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 144.279
Change
Ends at 01.07.26

Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $170.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 139.152
Change
Ends at 23.06.26

Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) had its price target raised by analysts at Piper Sandler from $76.00 to $160.00. They now have an "overweight" rating on the stock.
Ratings data for VRNA provided by MarketBeat
Show more